Clinical Trial: Suitability of Two Flavours of a High-energy, Low-protein Formula (Renalive(R) LP) in Chronic Kidney Disease Stage 3b-5 Outpatients in Taiwan

U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT06892249) titled 'Suitability of Two Flavours of a High-energy, Low-protein Formula (Renalive(R) LP) in Chronic Kidney Disease Stage 3b-5 Outpatients in Taiwan' on March 12.

Brief Summary: Purpose of study To evaluate suitability of two flavours of a high energy low protein formula (Renalive(R) LP) as oral nutritional supplement and meal replacement in chronic kidney disease stage 3b-5 outpatients Inclusion criteria (1) Diagnosed with chronic kidney disease stage 3b-5 (with history of eGFR30 kg/m2

4. Malnourished patients with albumin =3 loose or watery stools a day)

9. Swallowing difficulty or high risk of aspiration

10. Central nervous system a...